{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:24:55Z","timestamp":1787243095577,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.06.030","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T13:15:16Z","timestamp":1341234916000},"page":"1431-1437","source":"Crossref","is-referenced-by-count":11,"title":["An early (3\u20136 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria\u00ae in a province of Emilia-Romagna region, Italy \u2013 Part One"],"prefix":"10.1016","volume":"31","author":[{"given":"Silvia","family":"Candela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Cavuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Nobilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Dragosevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Groth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.06.030_bib0005","unstructured":"World Health Organization. Pandemic Influenza Preparedness and Response, Available at: http:\/\/whqlibdoc.who.int\/publications\/2009\/9789241547680_eng.pdf; 2009 [last accessed 23.04.12]."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0010","unstructured":"Italian Ministry of Health. New Influenza, Available at: http:\/\/www.nuovainfluenza.salute.gov.it\/nuovainfluenza\/nuovaInfluenza.jsp [last accessed 23.04.12]."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0015","unstructured":"European Medicines Agency. CHMP Recommendations for the Pharmacovigilance Plan as part of the Risk Management Plan to be submitted with the Marketing Authorisation Application for a Pandemic Influenza Vaccine, Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2010\/01\/WC500051739.pdf; 2009 [last accessed 23.04.12]."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0020","series-title":"Immunization safety review: influenza vaccines and neurological complications","author":"Institute of Medicine","year":"2004"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0025","series-title":"Adverse effects of vaccines: evidence and causality","author":"Institute of Medicine","year":"2012"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0030","unstructured":"Moro ML, Nobilio L, Voci C, Di Mario S, Candela S, Magrini N, and the SafFoH1N1 working group. A population based cohort study to assess the safety of pandemic influenza vaccine Focetria\u00ae in Emilia-Romagna region, Italy \u2013 Part two. Vaccine; in press."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0035","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1016\/j.vaccine.2011.08.093","article-title":"Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination","volume":"29","author":"Williams","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0040","unstructured":"VAESCO. Armonizing vaccine safety in Europe. Background rates, Available at: http:\/\/vaesco.net\/vaesco\/results\/BGR-2010.html [last accessed 23.04.12]."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0045","unstructured":"ClinicalTrails.Gov. Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine, Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01101074?term=NCT01101074&rank=1 [last accessed 23.04.12]."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0050","unstructured":"European Medicines Agency. Human Medicines. Focetria \u2013 Summary of Product Characteristics, Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000710\/WC500023749.pdf [last accessed 23.04.12]."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0055","first-page":"481","article-title":"Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus","volume":"84","author":"AAVV","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/01.AOG.0000218702.92005.bb","article-title":"Hospitalizations with respiratory illness among pregnant women during influenza season","volume":"107","author":"Cox","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0065","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0002-9378(03)00857-3","article-title":"Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season","volume":"189","author":"Hartert","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(09)61304-0","article-title":"H1N1 2009 influenza virus infection during pregnancy in the USA","volume":"374","author":"Jamieson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0075","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.43.19017-en","article-title":"National seasonal influenza vaccination survey in Europe, 2008","volume":"13","author":"Mereckiene","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/INF.0b013e31819d6394","article-title":"Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0085","unstructured":"Regione Emilia-Romagna. La nascita in Emilia-Romagna. 6(Rapporto sui dati del Certificato di assistenza al parto (CedAP) \u2013 anno 2008. Bologna: Regione Emilia-Romagna, Available at: http:\/\/www.regione.emilia-romagna.it\/sas\/cedap\/pubblicazioni.htm; 2009 [last accessed 23.04.12]."},{"key":"10.1016\/j.vaccine.2012.06.030_bib0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4161\/hv.7.5.14821","article-title":"Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations","volume":"7","author":"Banzhoff","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.06.030_bib0095","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.vaccine.2011.02.097","article-title":"Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination","volume":"29","author":"Parretta","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12008845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12008845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T09:20:48Z","timestamp":1561886448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12008845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X12008845"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}